Sugi Predict

Sugi Predict / Compounds / SCHEMBL701411

SCHEMBL701411

SCHEMBL701411

OCc1cnc2ccccc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.53
▸ CYP1A2 P05177 2/20 0.52
▸ PDGFRB P09619 2/20 0.50
▸ PDGFRA P16234 2/20 0.50
▸ MGAM O43451 1/20 0.50
▸ RAB9A P51151 2/20 0.47
▸ KDM1A O60341 1/20 0.47
▸ MAOA P21397 1/20 0.47
▸ MAOB P27338 1/20 0.47
▸ CFTR P13569 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.45
▸ KDM4E B2RXH2 2/20 0.44
▸ HPGD P15428 2/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ GFER P55789 1/20 0.44
▸ FAAH O00519 2/20 0.44
▸ PDE10A Q9Y233 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30831434 1.00 ALDH1A1 (0.53) ALDH1A1CYP1A2PDGFRBPDGFRAMGAM
Hydrochloric Acid SCHEMBL9433989 0.98 ALDH1A1 (0.51) ALDH1A1CYP1A2PDGFRBPDGFRAMGAM
Bromide SCHEMBL9399281 0.98 ALDH1A1 (0.51) ALDH1A1CYP1A2PDGFRBPDGFRAMGAM
Hydrochloric Acid SCHEMBL5833175 0.90 ALDH1A1 (0.45) ALDH1A1CYP1A2PDGFRBPDGFRAMGAM
SCHEMBL3995725 0.87 RAB9A (0.52) ALDH1A1CYP1A2PDGFRBPDGFRAMGAM
SCHEMBL5546916 0.85 ALDH1A1 (0.50) ALDH1A1CYP1A2PDGFRBPDGFRAMGAM
SCHEMBL3396692 0.83 CYP1A2 (0.55) ALDH1A1CYP1A2PDGFRBPDGFRAMGAM
SCHEMBL272057 0.82 ALDH1A1 (0.47) ALDH1A1CYP1A2PDGFRBPDGFRAMGAM
SCHEMBL9467100 0.80 ALDH1A1 (0.46) ALDH1A1CYP1A2PDGFRBPDGFRAMGAM
SCHEMBL26613461 0.80 PDGFRB (0.60) ALDH1A1CYP1A2PDGFRBPDGFRACYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 311 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113559904-B Application of nitrogen-carbon material anchored iron single-atom catalyst in catalyzing ammoxidation of alcohol to prepare nitrile 南京理工大学 2024-04-02 — — CN claimed
CN-113563337-B Preparation method of camelning alkali A 武汉理工大学 2023-07-04 — — CN claimed
CN-113559904-A Application of nitrogen-carbon material anchored iron monatomic catalyst in reaction for catalyzing ammoxidation of alcohol to prepare nitrile 南京理工大学 2021-10-29 — — CN claimed
CN-113563337-A Simple preparation method of camelinine A 武汉理工大学 2021-10-29 — — CN claimed
CN-103204807-A Synthetic method of 2-cyclopropyl-4-(4-fluoro-phenyl)-3-quinolinecarboxaldehyde YELLOW RIVER DELTA JINGBO CHEMICAL RES INST CO LTD 2013-07-17 — — CN claimed
CN-102256966-A Soluble mtor complexes and modulators thereof WHITEHEAD BIOMEDICAL INST 2011-11-23 — — CN claimed
EP-2350053-A2 SOLUBLE MTOR COMPLEXES AND MODULATORS THEREOF Whitehead Institute For Biomedical Research (US) 2011-08-03 — — EP claimed
WO-2010044885-A2 SOLUBLE MTOR COMPLEXES AND MODULATORS THEREOF WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2010-04-22 — — WO claimed
EP-0181568-A2 Anti-inflammatory/anti-allergic compounds RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1986-05-21 — — EP claimed
US-20260001846-A1 SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS SERVIER LAB (FR) 2026-01-01 — — US disclosed
CN-119816491-A New spirocyclohexane derivatives, pharmaceutical compositions containing them and their use as anti-apoptotic inhibitors 法国施维雅药厂 2025-04-11 — — CN disclosed
US-12016852-B2 Pyrrolidine glycosidase inhibitors ASCENEURON SA (CH) 2024-06-25 — — US disclosed
CN-115515956-B Benzimidazole derivative, and preparation method and medical application thereof 深圳信立泰药业股份有限公司 2024-06-25 — — CN disclosed
CN-117865966-A Carbamate compound, preparation method and medical application thereof 中国药科大学 2024-04-12 — — CN disclosed
US-4382931-A 3'-Substituted quinolinium cephalosporins ELI LILLY AND COMPANY (US) 1983-05-10 — — US disclosed
US-4379166-A Arylmethoxy-, arylmethylthio-, heteroarylmethoxy-, and heteroarylmethylthio-alkylaminoalcohols SCHERING CORPORATION (US) 1983-04-05 — — US disclosed
US-4282230-A Imidazolylethoxy derivatives of quinoline-2- or 4-methanols, antimicrobial compositions containing them and method for treating bacterial or fungal infections with them E. R. SQUIBB & SONS, INC. (US) 1981-08-04 — — US disclosed
US-4202985-A ANTIFUNGAL AND ANTIBACTERIAL AGENTS E. R. SQUIBB & SONS, INC. (US) 1980-05-13 — — US disclosed
US-4202985-A ANTIFUNGAL AND ANTIBACTERIAL AGENTS E. R. SQUIBB & SONS, INC. (US) 1980-05-13 — — US disclosed
US-4202985-A ANTIFUNGAL AND ANTIBACTERIAL AGENTS E. R. SQUIBB & SONS, INC. (US) 1980-05-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12016852-B2 Pyrrolidine glycosidase inhibitors PREP, GAA, DNPEP ALDH1A1 1182/4885CYP1A2 1540/4885PDGFRB 3098/4885
US-20260001846-A1 SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS BCL2, BCL2A1, BAX ALDH1A1 1848/4885CYP1A2 2158/4885PDGFRB 2539/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.